Non-puerperal uterine inversion due to uterine sarcomas represents a very rare event with no reliable estimate of frequency in the literature. Clinically, the diagnosis of inversion may be difficult, as far as imaging procedures are concerned, although ultrasonography may prove to be useful. However, some characteristics such as the indentation of the fundic area and a depressed longitudinal groove extending from the uterus to the center of the inverted portion are difficult to recognize. Moreover, there is no specific computed tomography feature accurate enough to aid in the differential diagnosis. Here, we report a case of uterine inversion due to Müllerian uterine adenosarcoma whose preoperative workup and diagnosis took advantage of the application of magnetic resonance imaging.

Keywords:
Müllerian adenosarcoma, Magnetic resonance imaging, Uterine inversion
1.
Case AS, Kirby TO, Conner MG, Huh WK: A case report of rhabdomyosarcoma of the uterus associated with uterine inversion. Gynecol Oncol 2005;96:850–853.
2.
Moodley M, Moodley J: Non-puerperal uterine inversion in association with uterine sarcoma: clinical management. Int J Gynecol Cancer 2003;13:244–245.
3.
Buyukkurt S, Vardar MA, Zeren A, Ozgunen FT: Non-puerperal inversion of the uterus caused by leiomiosarcoma: a case report and clinical management. J Obstet Gynaecol Res 2007;3:402–406.
4.
Lupovitch A, England ER, Chen R: Non-puerperal uterine inversion in association with uterine sarcoma: case report in a 26-year-old and review of the literature. Gynecol Oncol 2005;97:938–941.
5.
Hanprasertpong J, Wootipoom V, Hanprasertpon T: Non-puerperal uterine inversion and uterine sarcoma (malignant mixed müllerian tumor): report of an unusual case. J Obstet Gynaecol Res 2004;30:105–108.
6.
Takano K, Ichikawa Y, Tsunoda H, Nishida M: Uterine inversion caused by uterine sarcoma: a case report. Jpn J Clin Oncol 2001;31:39–42.
7.
Acharaya S, Hensley ML, Montag AC, Fleming GF: Rare uterine cancers. Lancet Oncol 2005;6:961–971.
8.
Brown MA, de Abreu HR: MR imaging of malignant uterine disease. Magn Reson Imaging Clin North Am 2007;14:455–469.
© 2012 S. Karger AG, Basel
2012
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.